The Delaware Research and Development Tax Credit, governed by Del. Code Ann. tit. 30, §§ 2070-2075 and administered by the Delaware Division of Revenue, incentivizes innovation by providing a fully refundable credit for qualified research expenses (QREs) conducted within the state. This credit offsets corporate income tax liabilities or results in direct cash refunds for unused portions, making it particularly valuable for startups and growth-stage companies in sectors like biotechnology, finance, and manufacturing.
Eligibility requires conducting qualified research activities (QRAs) in Delaware that meet federal standards under IRC § 41, with QREs apportioned to the state based on activities performed within its borders. Businesses must apply annually for approval from the Delaware Division of Revenue.
All QREs must meet the definitions and substantiation requirements of IRC § 41(b) (e.g., must be documented, directly related to qualified research, and not merely overhead or non-eligible costs).
Delaware offers two elective methods for calculating the credit: the regular incremental method or a share of the federal Alternative Simplified Credit (ASC). Both use only Delaware-apportioned QREs. The election is made annually on the application (Form 2070AC) and applies to the entire credit for that year. Taxpayers must maintain records of prior 4 years’ Delaware QREs and gross receipts, since that data is required for Form 2070AC.
Delaware's R&D credit features unique provisions for refunds, small businesses, and application processes that distinguish it from federal rules and enhance cash flow for innovators.
A Delaware-based fintech startup recovered significant refunds through targeted R&D claims.
The Delaware R&D Tax Credit provides a fully refundable incentive equal to 10% of excess qualified research expenses over the base amount (20% for businesses with < $20M gross receipts) or 50% of the apportioned federal ASC (100% for small businesses), administered under Del. Code Ann. tit. 30, § 2070.
Eligible activities mirror federal IRC § 41: technological in nature, aimed at developing or improving products/processes, eliminating uncertainty, and involving experimentation—all performed in Delaware. Strike Tax identifies qualifying projects like software prototyping or process improvements.
Savings depend on actual eligible QREs, base-amount history, federal election, and qualified tax liability. For example, for $1M in excess QREs, a standard business may save $100,000 (10%), while small businesses may save $200,000 (20%). Stack with federal credits for potentially up to $300,000 total. Use Strike Tax’s R&D Credit Calculator for personalized estimates.
Yes, fully refundable—unused portions exceeding tax liability are paid as cash by the Delaware Division of Revenue.
Submit Delaware’s R&D credit application and computation schedule (currently Form 2070AC or successor form) by September 15 for approval, then transfer to Form 700 with your income tax return. Strike Tax handles documentation, apportionment, and filing to ensure compliance.
Yes, the state credit is calculated independently and can be stacked with federal credits for the same Delaware QREs, maximizing savings depending on your specific circumstances. Strike Tax optimizes claims across both programs.
Businesses that meet Delaware’s small business test (generally, average annual gross receipts under 20 million dollars, determined under federal R&D credit rules and adjusted periodically for inflation) qualify for 20% on excess QREs (vs. 10% standard) or 100% of the apportioned federal ASC (vs. 50% standard), significantly boosting incentives for startups and mid-sized firms in high-innovation sectors.
Base = fixed-base percentage × average Delaware gross receipts over prior 4 years (min. 50% of current QREs). Delaware’s fixed base percentage is the ratio of Delaware QREs to gross receipts for the 4 preceding years. If fewer than 4 years with both, use available years; if none, fixed base percentage is zero. Gross receipts follow Delaware apportionment rules and are not limited to Delaware-delivered sales.
No, the credit remains available even if the federal R&D credit is terminated, per § 2073, though it incorporates IRC § 41 definitions.
Strike Tax ensures full compliance with Delaware's apportionment rules, maximizes refunds via the small biz rate or ASC election, and streamlines applications for tech and manufacturing clients.